ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report
Amsterdam, The Netherlands – 3 July 2019
read more
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report
Amsterdam, The Netherlands – 3 July 2019
read more
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
CEO, Frédéric Amar, has converted part of his loan notes into 2.5 million shares to support the business and L1 Capital has continued financing the Company.
Amsterdam, The Netherlands – 30 June 2019
read more
Esperite N.V. (ESP): Update to the market on the publication of the Annual Report 2018
Amsterdam, The Netherlands – 28 June 2019
read more
ESPERITE N.V. (Euronext: ESP, “Esperite”, “the Company” or “the Group”) has published today its Annual Report for the year ended 31 December 2017. The 2017 Annual Report is now available on the Company’s website www.esperite.com.
Amsterdam, The Netherlands – 23 November 2018
ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
Amsterdam, The Netherlands – 19 November 2018
read more
ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
Amsterdam, The Netherlands – 09 November 2018
read more
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 31 August 2018
read more
Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 15 August 2018
read more
Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 18 July 2018
read more
ESPERITE (ESP) further delays publication of Annual Report 2017.
Amsterdam, The Netherlands – 18 June 2018